Jaguar Health JAGX
NASDAQ JAGX
$3.95 -0.55 (-12.22%)
At close: Oct 1, 2026 · 4:00 PM EDT

Jaguar Health (JAGX) Cash from Financing Activities (2014 - 2026)

Updated

Jaguar Health's Cash from Financing Activities was $1.86 million in Q2 2026, down 29.9% from $2.66 million a year earlier.

Analysis

Jaguar Health (JAGX) Cash from Financing Activities (2014 - 2026) Analysis & Trends

On a trailing twelve-month basis, Jaguar Health's Cash from Financing Activities was $11.3 million through Jun 30, 2026, down 19.2% year-over-year; for FY2025, it was $23.67 million, down 24.1% from FY2024.

  • Cash from Financing Activities shows a five-year compound annual growth rate of 4.0% (FY2020 to FY2025).
  • In earlier years, Cash from Financing Activities was $31.2 million in FY2024 (-8.8%), $34.23 million in FY2023 (+47.7%), $23.18 million in FY2022 (-47.2%) and $43.94 million in FY2021 (+125.4%).
  • Quarterly Cash from Financing Activities has moved between -$6.62 million (Q1 2026) and $18.81 million (Q1 2023) over five years.
  • Compared with a year earlier, Cash from Financing Activities was higher in three of the last seven quarters, with growth averaging 33.2%.
  • The best year-over-year quarter for Cash from Financing Activities over five years was Q4 2023 (growth of 550.2%); the worst was Q3 2023 (a decline of 86.1%).
  • Per Business Quant data, JAGX's Cash from Financing Activities in the three quarters before Q2 2026 was -$6.62 million (Q1 2026), $9.79 million (Q4 2025) and $6.26 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -8.78 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -5.05 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.76 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -2.02 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -47.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -1.48 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 2.34 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -3.66 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -426.70 Mn
10 Jaguar Health 720,234.00 -16.53 Mn 194,000.00 1.86 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.86 Mn
Mar 31, 2026 -6.62 Mn
Dec 31, 2025 9.79 Mn
Sep 30, 2025 6.26 Mn
Jun 30, 2025 2.66 Mn
Mar 31, 2025 4.97 Mn
Dec 31, 2024 2.83 Mn
Sep 30, 2024 3.53 Mn
Jun 30, 2024 12.57 Mn
Mar 31, 2024 12.27 Mn
Dec 31, 2023 10.65 Mn
Sep 30, 2023 1.41 Mn
Jun 30, 2023 3.36 Mn
Mar 31, 2023 18.81 Mn
Dec 31, 2022 1.64 Mn
Sep 30, 2022 10.15 Mn
Jun 30, 2022 3.25 Mn
Mar 31, 2022 8.15 Mn
Dec 31, 2021 3.12 Mn
Sep 30, 2021 373,000.00
API Access

Jaguar Health Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=JAGX&period=max&api_key=YOUR_API_KEY